Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Taegwon Oh"'
Autor:
Chel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, Eun-Suk Kang, Duck Cho, Yong-Man Kim, Kidong Kim, Jae-Weon Kim, Hee Seung Kim, Young-Tae Kim, Jung-Yun Lee, Myong Cheol Lim, Taegwon Oh, Boyeong Song, Insu Jeon, Myunghwan Park, Wu Hyun Kim, Chang-Yuil Kang, Byoung-Gie Kim
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundBVAC-C, a B cell– and monocyte-based immunotherapeutic vaccine transfected with recombinant HPV E6/E7, was well tolerated in HPV–positive recurrent cervical carcinoma patients in a phase I study. This phase IIa study investigates the an
Externí odkaz:
https://doaj.org/article/25f6fbb234fe45fb87de005ce22849a5
Autor:
Seung-Phil Shin, Kwang-Soo Shin, Jeong-Mi Lee, In-Kyung Jung, Jimo Koo, Seung-Woo Lee, Seowoo Park, Jieun Shin, Myunghwan Park, Bongju Park, Hanseul Oh, Bon-Sang Koo, Jungjoo Hong, Choong-Min Ryu, Jae-Ouk Kim, Taegwon Oh, Chang-Yuil Kang
Publikováno v:
Vaccines, Vol 10, Iss 5, p 712 (2022)
Several COVID-19 platforms have been licensed across the world thus far, but vaccine platform research that can lead to effective antigen delivery is still ongoing. Here, we constructed AdCLD-CoV19 that could modulate humoral immunity by harboring SA
Externí odkaz:
https://doaj.org/article/8e67b259b29c4f68ae9f11342ff14fd7
Autor:
Hyungseok Seo, Insu Jeon, Byung-Seok Kim, Myunghwan Park, Eun-Ah Bae, Boyeong Song, Choong-Hyun Koh, Kwang-Soo Shin, Il-Kyu Kim, Kiyoung Choi, Taegwon Oh, Jiyoun Min, Byung Soh Min, Yoon Dae Han, Suk-Jo Kang, Sang Joon Shin, Yeonseok Chung, Chang-Yuil Kang
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-14 (2017)
Loss of major histocompatibility complex MHC-I expression contributes to cancer immune evasion. Here, the authors show that, in both mice and humans, MHC-I downregulation is associated with the induction of NK-cell exhaustion and that IL-21 restores
Externí odkaz:
https://doaj.org/article/2bd96612eae447d095ca7886cae7e6ec
Autor:
Chel Hun Choi, Hyun Jin Choi, Jeong-Won Lee, Eun-Suk Kang, Duck Cho, Byung Kwan Park, Yong-Man Kim, Dae-Yeon Kim, Hyungseok Seo, Myunghwan Park, Wuhyun Kim, Ki-Young Choi, Taegwon Oh, Chang-Yuil Kang, Byoung-Gie Kim
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 1, p 147 (2020)
BVAC-C is a B cell-based and monocyte-based immuno-therapeutic vaccine transfected with a recombinant human papillomavirus (HPV) 16/18 E6/E7 gene and loaded with alpha-galactosyl ceramide, which is a natural killer T cell ligand. This phase I study s
Externí odkaz:
https://doaj.org/article/0072566c95814a32ac75cc52d26b8ddc
Autor:
Thierry Christophe, Mary Jackson, Hee Kyoung Jeon, Denis Fenistein, Monica Contreras-Dominguez, Jaeseung Kim, Auguste Genovesio, Jean-Philippe Carralot, Fanny Ewann, Eun Hye Kim, Sae Yeon Lee, Sunhee Kang, Min Jung Seo, Eun Jung Park, Henrieta Skovierová, Ha Pham, Giovanna Riccardi, Ji Youn Nam, Laurent Marsollier, Marie Kempf, Marie-Laure Joly-Guillou, Taegwon Oh, Won Kyung Shin, Zaesung No, Ulf Nehrbass, Roland Brosch, Stewart T Cole, Priscille Brodin
Publikováno v:
PLoS Pathogens, Vol 5, Iss 10, p e1000645 (2009)
A critical feature of Mycobacterium tuberculosis, the causative agent of human tuberculosis (TB), is its ability to survive and multiply within macrophages, making these host cells an ideal niche for persisting microbes. Killing the intracellular tub
Externí odkaz:
https://doaj.org/article/99417d33f11047f2814f85afb272f7e0
Autor:
Minkyu Jung, Jii Bum Lee, Hyo Song Kim, Woo Sun Kwon, Hyun Ok Kim, Sinyoung Kim, Myunghwan Park, Wuhyun Kim, Ki-Young Choi, Taegwon Oh, Chang-Yuil Kang, Hyun Cheol Chung, Sun Young Rha
Publikováno v:
Cancer Research & Treatment; Jan2024, Vol. 56 Issue 1, p208-218, 11p
Autor:
Seung-Phil Shin, Kwang-Soo Shin, Jeong-Mi Lee, In-Kyung Jung, Jimo Koo, Seung-Woo Lee, Seowoo Park, Jieun Shin, Myunghwan Park, Bongju Park, Hanseul Oh, Bon-Sang Koo, Jungjoo Hong, Choong-Min Ryu, Jae-Ouk Kim, Taegwon Oh, Chang-Yuil Kang
Publikováno v:
Vaccines; Volume 10; Issue 5; Pages: 712
Several COVID-19 platforms have been licensed across the world thus far, but vaccine platforms research that can lead to effective antigen delivery is still ongoing. Here, we constructed AdCLD-CoV19 that could modulate humoral immunity by harboring S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76329050720d2006dd90c0d26f13dae8
https://doi.org/10.20944/preprints202204.0072.v1
https://doi.org/10.20944/preprints202204.0072.v1
Autor:
Taegwon Oh, Hyun Jin Choi, Byung Kwan Park, Duck Cho, Ki-Young Choi, Chel Hun Choi, Eun-Suk Kang, Dae Yeon Kim, Yong-Man Kim, Byoung-Gie Kim, Wuhyun Kim, Myung Hwan Park, Hyungseok Seo, Chang-Yuil Kang, Jeong-Won Lee
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 1
Journal of Clinical Medicine, Vol 9, Iss 1, p 147 (2020)
Volume 9
Issue 1
Journal of Clinical Medicine, Vol 9, Iss 1, p 147 (2020)
BVAC-C is a B cell-based and monocyte-based immuno-therapeutic vaccine transfected with a recombinant human papillomavirus (HPV) 16/18 E6/E7 gene and loaded with alpha-galactosyl ceramide, which is a natural killer T cell ligand. This phase I study s
Autor:
Kidong Kim, Yong-Man Kim, Taegwon Oh, Duck Cho, Myong Cheol Lim, Chel Hun Choi, Jae Weon Kim, Chang-Yuil Kang, Eun-Suk Kang, Jung Yun Lee, Duk-Soo Bae, Jeong-Won Lee, Hee Seung Kim, Young Tae Kim, Byoung-Gie Kim
Publikováno v:
Journal of Clinical Oncology. 39:5512-5512
5512 Background: BVAC-C is a B cell- and monocyte-based immunotherapeutic vaccine transfected with recombinant HPV E6/E7, which was well tolerated in HPV positive recurrent cervical carcinoma in phase I study (J Clin Med. 2020 Jan 5;9(1):147). This p
Autor:
Jiyoun Min, Sang Joon Shin, Myung Hwan Park, Chang-Yuil Kang, Yeonseok Chung, Ki-Young Choi, Byung Soh Min, Hyungseok Seo, Yoon Dae Han, Choong-Hyun Koh, Boyeong Song, Suk-Jo Kang, Insu Jeon, Il-Kyu Kim, Eun-Ah Bae, Byung-Seok Kim, Taegwon Oh, Kwangsoo Shin
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-14 (2017)
Nature Communications
NATURE COMMUNICATIONS(8)
Nature Communications
NATURE COMMUNICATIONS(8)
During cancer immunoediting, loss of major histocompatibility complex class I (MHC-I) in neoplasm contributes to the evasion of tumours from host immune system. Recent studies have demonstrated that most natural killer (NK) cells that are found in ad